박진원 (서울대학교 약학대학)님 | 한빛사연구자 > 한빛사

서울대학교 약학대학

바이오센싱 및 나노바이오물질

최종업데이트 2024.06.24.

Self-disassembling nanoparticles as oral nanotherapeutics targeting intestinal microenvironment
- Nat. Commun., 09 April 2025 | https://doi.org/10.1038/s41467-025-58513-y
- 2025-04
- 의약학
- 한빛사논문
MicroRNA-induced reprogramming of tumor-associated macrophages for modulation of tumor immune microenvironment
- J. Control. Release, Feb 28 2025, S0168-3659(25)00202-0 | https://doi.org/10.1016/j.jconrel.2025.113593
- 2025-02
- 의약학
- 한빛사논문
Anti-Inflammatory Macrophage-Derived Exosomes Modified With Self-Antigen Peptides for Treatment of Experimental Autoimmune Encephalomyelitis
- Adv. Sci., Feb 12 2025, | https://doi.org/10.1002/advs.202415265
- 2025-02
- 의약학
- 한빛사논문
NET formation-mediated in situ protein delivery to the inflamed central nervous system
- Nat. Commun., Dec 30 2024, 15 (1) | https://doi.org/10.1038/s41467-024-54817-7
- 2024-12
- 의약학
- 한빛사논문
Cytoskeleton-modulating nanomaterials and their therapeutic potentials
- Adv. Drug Deliv. Rev., Jun 19 2024, S0169-409X(24)00184-4 | https://doi.org/10.1016/j.addr.2024.115362
- 2024-06
- 의약학
- 한빛사논문
Lysyl oxidase-responsive anchoring nanoparticles for modulation of the tumor immune microenvironment
- J. Control. Release, Available online 10 July 2023 | https://doi.org/10.1016/j.jconrel.2023.06.041
- 2023-07
- 의약학
- 한빛사논문
Tolerogenic Nanovaccine for Prevention and Treatment of Autoimmune Encephalomyelitis
- Adv. Mater., 2022 Oct 8;e2202670 | https://doi.org/10.1002/adma.202202670
- 2022-10
- 의약학
- 한빛사논문
Biochemical reprogramming of tumors for active modulation of receptor-mediated nanomaterial delivery
- Biomaterials, Available online 2 September 2020, 120343 | https://doi.org/10.1016/j.biomaterials.2020.120343
- 2020-09
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기